echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Will SARS-CoV-2, everyone's "talk of color change," be the next big pop "Terminator"?

    Will SARS-CoV-2, everyone's "talk of color change," be the next big pop "Terminator"?

    • Last Update: 2021-02-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In fact, the idea that viruses might interfere with each other has been around since the 18th century, when British doctor Edward Jenner found that if people with herpes were vaccinated against flux, the vaccine's effectiveness would be much reduced, suggesting that both viruses could alter the immune system's regulatory mechanisms.
    Later, a growing number of scientists discovered the interference between viruses, and in a review article published in the journal The Journal of Immunology in 1950, researchers summarized the literature and called it a "well-known fact", but its rationale was unclear, so constant exploration was needed to verify the authenticity of the magical phenomenon of "poisoning".
    the case of AIDS, once known as the plague of the century, but a number of early studies have found that the hepatitis E virus (HGV) appears to be the star of the powerful HIV virus! If a patient is infected with hiv and HIV at the same time, the rate of onset and deterioration is significantly reduced.
    HGV may have the effect of alleviating the development of HIV? In this regard, the researchers speculate that it may be that some unknown mechanism of HGV activates the body's immune system, increasing the number of CD4-T cells in the body, and that hiv replication is inhibited in cells infected with both HIV and HIV, thus eliminating HIV symptoms.
    not only that, but in October 2020, researchers at Yale University published an article in The Lancet entitled "Process between rhinovirus and influenza A virus: a clinical data analysis and analysis" that once the congenital immune system is activated, the body rejects another virus invader.
    In the study, researchers inoculated people with respiratory tissue cultured with rhinovirus and IAV three days after infection, AND RT-qPCR showed that the load of rhinoviruses decreased more than 15 times in the 24 hours and 48 hours after IAV infection, suggesting that rhinovirus infection can induce an antiviral response in human respiratory superskine cells, which persists on the third day after infection, and that nasal infection may interfere with subsequent IAV infections.
    means that a respiratory virus can block another infection by stimulating antiviral defenses in the mucous membranes of the airways.
    And if the nasal virus is first inoculated in in-body cultured respiratory tissue and then IAVI is inoculated, the antiviral interferon response, which playes an important role in the host's resistance to viral infection, is activated in advance, thus achieving the effect of suppressing IAVI infection and reducing the replication of the virus.
    That is, in the future, in the fight against influenza viruses such as IAV, it may be able to use a virus-made nasal spray to produce a protective interferon reaction in the human body, prevent the threat of more terrible diseases through benign infections, and prevent the occurrence of infectious diseases.
    because the immune response is the result of evolving between humans and viruses, it is not known that certain viruses may be beneficial rather than harmful to us.
    During the COVID-19 pandemic, many cases of respiratory infections plummeted, which may be the result of "masks", but it is not ruled out that the results of virus interference may be involved, perhaps the COVID-19 epidemic is further suppressing influenza, on the contrary, influenza may also slow the spread of COVID-19, but all this can only be confirmed by further research.
    resources: s1 s 2 s
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.